Canine leptospirosis: Clinical and molecular diagnosis associated therapeutic management

Simple item page
dc.contributor.authorGeetha, M
dc.contributor.authorSelvaraju, G
dc.contributor.authorTANUVAS
dc.date.accessioned2021-12-08T11:02:38Z
dc.date.available2021-12-08T11:02:38Z
dc.date.issued2021
dc.descriptionTNV_PIJ_2021_SP 10(9)264-266en_US
dc.description.abstractCanine leptospirosis is an important zoonotic disease caused by the species of the spirochete genus Leptospira. There are more than 250 serovars of Leptospira were identified throughout the world and atleast ten of them including Australis, Autumnalis, Canicola, Grippothyphosa, Hardjo, Icterohaemorrhagiae, Pomona, Saxkoebing and Sejroe are being reported in association of canine leptospirosis throughout the globe. Four dogs of different age group and breeds with the history of pyrexia, anorexia, vomiting and enteritis were reported to the infectious disease unit of Veterinary Clinical Complex, Veterinary College and Research Institute, Namakkal for therapeutic intervention. Pale pink mucous membrane, hematochezia, pyrexia, tachypnea, shivering, dehydration, oliguria with mild cough were the predominant clinical examination findings in all animals and one had icterus. Anemia (mean - 8.2 + 2.1 g/dl), leucocytosis (25.1 + 4.2 x 103/ μl) mild thrombocytopaenia (mean - 1.2 + 0.2 x 103/ μl) were notifiable haemato-biochemical changes noticed in all animals. Extracted template DNA from sera of all dogs were subjected to polymerase chain reaction targeting Lip L 32 gene specific for pathogenic Leptospires detected positive for infection. Doxycycline @ of 10 mg/kg body weight once daily for 21 days along with supportive therapy ended in uneventful recovery of all four dogs.en_US
dc.identifier.urihttps://krishikosh.egranth.ac.in/handle/1/5810178858
dc.keywordscanine leptospirosis, PCR, therapyen_US
dc.language.isoEnglishen_US
dc.pages264-266en_US
dc.relation.ispartofseriesSP;9
dc.subjectVeterinary Scienceen_US
dc.titleCanine leptospirosis: Clinical and molecular diagnosis associated therapeutic managementen_US
dc.title.alternativeThe Pharma Innovation Journalen_US
dc.typeArticleen_US
dc.volume10en_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
TNV_PIJ_2021_SP 10(9)264-266.pdf
Size:
214.01 KB
Format:
Adobe Portable Document Format
Description:
TNV_PIJ_2021_SP 10(9)264-266
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Articles (1.Journal)